Howard Hughes Medical Institute and Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Cell. 2019 Jan 24;176(3):479-490.e12. doi: 10.1016/j.cell.2018.12.006. Epub 2019 Jan 10.
The angiotensin II (AngII) type 1 receptor (AT1R) is a critical regulator of cardiovascular and renal function and is an important model for studies of G-protein-coupled receptor (GPCR) signaling. By stabilizing the receptor with a single-domain antibody fragment ("nanobody") discovered using a synthetic yeast-displayed library, we determined the crystal structure of active-state human AT1R bound to an AngII analog with partial agonist activity. The nanobody binds to the receptor's intracellular transducer pocket, stabilizing the large conformational changes characteristic of activated GPCRs. The peptide engages the AT1R through an extensive interface spanning from the receptor core to its extracellular face and N terminus, remodeling the ligand-binding cavity. Remarkably, the mechanism used to propagate conformational changes through the receptor diverges from other GPCRs at several key sites, highlighting the diversity of allosteric mechanisms among GPCRs. Our structure provides insight into how AngII and its analogs stimulate full or biased signaling, respectively.
血管紧张素 II(AngII)型 1 受体(AT1R)是心血管和肾功能的关键调节剂,也是 G 蛋白偶联受体(GPCR)信号转导研究的重要模型。通过使用合成酵母展示文库发现的单域抗体片段(“纳米抗体”)稳定受体,我们确定了与具有部分激动剂活性的 AngII 类似物结合的活性状态人 AT1R 的晶体结构。纳米抗体结合到受体的细胞内转导口袋,稳定了激活 GPCR 的大构象变化特征。该肽通过从受体核心到其细胞外表面和 N 端的广泛界面与 AT1R 结合,重塑配体结合腔。值得注意的是,通过受体传播构象变化的机制在几个关键位点与其他 GPCR 不同,突出了 GPCR 之间变构机制的多样性。我们的结构提供了关于 AngII 及其类似物如何分别刺激完全或偏向信号转导的见解。